Ivarmacitinib in patients with active ankylosing spondylitis: subgroup analysis based on key baseline features from a phase II/III trial.

AiSuDa (ivarmacitinib) - Jiangsu Hengrui Pharma, Arcutis

http://www.ncbi.nlm.nih.gov/pubmed/42518036

Bei Xu; Chuanyin Sun; Danyi Xu; Heng Cao; Jin Lin; Liqin Xu; Weiqian Chen; Yiduo Sun; Yini Ke

Jul 29, 2026